Moreover, a network interaction map of invadopodia-associated proteins has demonstrated a central role for the EGFR-Pyk-Src-Arg-cortactin invadopodial pathway, in which repurposing of existent inhibitors could be applied for blocking breast cancer metastasis [44]. Here, SRC is linked to breast carcinoma.